Global Outreach Kala-azar Elimination Programme


Kala-azar has been a serious medical and public health problem in India since historical times. Bengal is the oldest known Kala-azar endemic area of the world. After the initial success, Kala-azar resurged in 70s. Concerned with the increasing problem of Kala-azar in the country, the Government of India (GOI) launched a centrally sponsored Kala-azar Control Programme in the endemic states in 1990-91. The GoI provided drugs, insecticides and technical support and state governments provided costs involved in implementation. The program was implemented through State/District Malaria Control Offices and the primary health care system. The programme brought a significant decline in Kala-azar morbidity, but could not sustain the pace of decline for long.

The National Health Policy-2002 set the goal of Kala-azar elimination in India by the year 2010 which was revised to 2015. Continuing focused activities with high political commitment, India signed a Tripartite Memorandum of Understanding (MoU) with Bangladesh and Nepal to achieve Kala-azar elimination from the South-East Asia Region (SEAR). Elimination is defined as reducing the annual incidence of Kala-azar to less than 1 case per 10,000 population at the sub-district (block PHCs) level in Bangladesh and India and at the district level in Nepal.
Presently all programmatic activities are being implemented through the National Vector Borne Disease Control Programme (NVBDCP) which is an umbrella programme for prevention & control of vector borne diseases and is subsumed under National Health Mission (NHM).
To improve the health status of vulnerable groups and at-risk population living in Kala-azar endemic areas by the elimination of Kala-azar so that it no longer remains a public health problem.
To reduce the annual incidence of Kala-azar to less than one per 10,000 populations at block PHC level.
To reduce the annual incidence of Kala-azar to less than one per 10 000 population at block PHC level by the end of 2018 by:
reducing Kala-azar in the vulnerable, poor and unreached populations in endemic areas;
reducing case-fatality rates from Kala-azar to negligible level;
reducing cases of PKDL to interrupt transmission of Kala-azar; and
preventing the emergence of Kala-azar and HIV/TB co-infections in endemic areas.